Elizabeth Tullis

European Respiratory Journal, The Lancet Respiratory Medicine, American Journal of Respiratory and Critical Care Medicine
6
Role Title Level Year L/R
🐜 Long-term safety and efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis and at least one F508del allele: 144-week interim results from a 192-week open-label extension study
23 auth. C. Daines, Elizabeth Tullis, Stefano Costa, Rachel W. Linnemann, M. A. Mall, E. McKone, Deepika Polineni, B. Quon, F. C. Ringshausen, Steven M. Rowe, ... H. Selvadurai, J. Taylor-Cousar, Nicholas J. Withers, N. Ahluwalia, Samuel M. Moskowitz, Valentin Prieto-Centurion, Yaoyuan Vincent Tan, S. Tian, T. Weinstock, Fengjuan Xuan, Yaohua Zhang, Bonnie Ramsey, Matthias Griese 		5 2023 5
🐜
🐜 Long-term safety and efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis and at least one F508del allele: 144-week interim results from a 192-week open-label extension study
23 auth. C. Daines, Elizabeth Tullis, Stefano Costa, Rachel W. Linnemann, M. A. Mall, E. McKone, Deepika Polineni, B. Quon, F. C. Ringshausen, Steven M. Rowe, ... H. Selvadurai, J. Taylor-Cousar, Nicholas J. Withers, N. Ahluwalia, Samuel M. Moskowitz, Valentin Prieto-Centurion, Yaoyuan Vincent Tan, S. Tian, T. Weinstock, Fengjuan Xuan, Yaohua Zhang, Bonnie Ramsey, Matthias Griese 		5 2023 5
🐜
🐜 Elexacaftor/Tezacaftor/Ivacaftor Treatment and Depression-related Events
12 auth. Bonnie Ramsey, Christoph U. Correll, D. DeMaso, E. McKone, Elizabeth Tullis, J. Taylor-Cousar, ... C. Chu, Nataliya Volkova, N. Ahluwalia, David Waltz, S. Tian, M. A. Mall 		4 2023 4
🐜
🐜 Vanzacaftor-tezacaftor-deutivacaftor versus elexacaftor-tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103): results from two randomised, active-controlled, phase 3 trials.
25 auth. C. Keating, L. Yonker, F. Vermeulen, Dario Prais, Rachel W Linnemann, A. Trimble, T. Kotsimbos, Joel Mermis, Andrew T Braun, M. O'Carroll, S. Sutharsan, Bonnie Ramsey, M. A. Mall, J. Taylor-Cousar, E. McKone, ... Elizabeth Tullis, T. Floreth, P. Michelson, P. Sosnay, N. Nair, Rachel Zahigian, Hannah Martin, N. Ahluwalia, A. Lam, A. Horsley 		3 2024 3
🐜
🐜 A randomised trial of oral prednisone for cystic fibrosis pulmonary exacerbation treatment
20 auth. Valerie Waters, M. Shaw, L. Perrem, Bradley S. Quon, Elizabeth Tullis, M. Solomon, J. Rayment, A. Lavoie, S. Tse, P. Daigneault, ... L. Bilodeau, April Price, Michael Nicholson, Melanie Chin, M. Parkins, Martha L. McKinney, Julian S Tam, Sanja Stanojevic, Hartmut Grasemann, F. Ratjen 		3 2024 3
🐜
🐜 Vanzacaftor-tezacaftor-deutivacaftor for children aged 6-11 years with cystic fibrosis (RIDGELINE Trial VX21-121-105): an analysis from a single-arm, phase 3 trial.
18 auth. J. Hoppe, Ajay S Kasi, Jessica E Pittman, Renee Jensen, Lena P Thia, Philip Robinson, Pornchai Tirakitsoontorn, Bonnie Ramsey, M. A. Mall, J. Taylor-Cousar, ... E. McKone, Elizabeth Tullis, Danieli B Salinas, Jiaqiang Zhu, Yih-Chieh Chen, Violeta Rodriguez-Romero, P. Sosnay, Gwyneth Davies 		2 2024 2
🐜